- AuthorisedTherapeutic exploratory (Phase II)
OSU6162 as add-on in SSRI/SNRI-resistant depression (ODEN): a double-blind, placebo-controlled evaluation of efficacy and safety
This study is looking into a new treatment called OSU6162 for people with depression that hasn't improved with usual medications like SSRIs or SNRIs. It compares OSU6162 to a dummy pill (placebo) to see if it helps reduce depression symptoms and if it's safe.
For: DepressionSweden - AuthorisedTherapeutic exploratory (Phase II)
OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID)
This study is looking into a new medication called OSU6162 for people with bipolar depression. It hopes to see if this medicine can help improve symptoms of depression. Participants will take the medicine, and doctors will monitor their mood over a couple of months.
For: Bipolar depressionSweden